nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—epilepsy syndrome	0.746	1	CbGaD
Icatibant—Injection site reaction—Amobarbital—epilepsy syndrome	0.0032	0.0341	CcSEcCtD
Icatibant—Injection site reaction—Phenobarbital—epilepsy syndrome	0.0024	0.0256	CcSEcCtD
Icatibant—BDKRB2—head—epilepsy syndrome	0.00214	0.133	CbGeAlD
Icatibant—BDKRB2—nervous system—epilepsy syndrome	0.00203	0.126	CbGeAlD
Icatibant—BDKRB2—central nervous system—epilepsy syndrome	0.00195	0.122	CbGeAlD
Icatibant—BDKRB2—cerebellum—epilepsy syndrome	0.00191	0.119	CbGeAlD
Icatibant—ANPEP—medulla oblongata—epilepsy syndrome	0.00168	0.105	CbGeAlD
Icatibant—Injection site reaction—Fosphenytoin—epilepsy syndrome	0.00166	0.0177	CcSEcCtD
Icatibant—Injection site reaction—Diazepam—epilepsy syndrome	0.00159	0.0169	CcSEcCtD
Icatibant—BDKRB2—brain—epilepsy syndrome	0.00155	0.0966	CbGeAlD
Icatibant—Injection site reaction—Phenytoin—epilepsy syndrome	0.00145	0.0154	CcSEcCtD
Icatibant—ANPEP—head—epilepsy syndrome	0.00133	0.0831	CbGeAlD
Icatibant—ANPEP—nervous system—epilepsy syndrome	0.00126	0.0788	CbGeAlD
Icatibant—ANPEP—central nervous system—epilepsy syndrome	0.00122	0.0759	CbGeAlD
Icatibant—Nervous system disorder—Primidone—epilepsy syndrome	0.00109	0.0115	CcSEcCtD
Icatibant—Injection site reaction—Valproic Acid—epilepsy syndrome	0.00106	0.0113	CcSEcCtD
Icatibant—ANPEP—brain—epilepsy syndrome	0.000967	0.0602	CbGeAlD
Icatibant—Injection site reaction—Pregabalin—epilepsy syndrome	0.000958	0.0102	CcSEcCtD
Icatibant—Body temperature increased—Amobarbital—epilepsy syndrome	0.000909	0.00966	CcSEcCtD
Icatibant—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000847	0.009	CcSEcCtD
Icatibant—Nervous system disorder—Rufinamide—epilepsy syndrome	0.000831	0.00883	CcSEcCtD
Icatibant—Nervous system disorder—Lacosamide—epilepsy syndrome	0.00078	0.00829	CcSEcCtD
Icatibant—Dizziness—Amobarbital—epilepsy syndrome	0.00076	0.00808	CcSEcCtD
Icatibant—Nervous system disorder—Clobazam—epilepsy syndrome	0.000757	0.00805	CcSEcCtD
Icatibant—Dizziness—Primidone—epilepsy syndrome	0.000733	0.00779	CcSEcCtD
Icatibant—Rash—Amobarbital—epilepsy syndrome	0.000725	0.00771	CcSEcCtD
Icatibant—Dermatitis—Amobarbital—epilepsy syndrome	0.000724	0.0077	CcSEcCtD
Icatibant—Headache—Amobarbital—epilepsy syndrome	0.00072	0.00766	CcSEcCtD
Icatibant—Rash—Primidone—epilepsy syndrome	0.000698	0.00742	CcSEcCtD
Icatibant—Dermatitis—Primidone—epilepsy syndrome	0.000698	0.00742	CcSEcCtD
Icatibant—Headache—Primidone—epilepsy syndrome	0.000694	0.00738	CcSEcCtD
Icatibant—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000688	0.00731	CcSEcCtD
Icatibant—Nausea—Amobarbital—epilepsy syndrome	0.000683	0.00726	CcSEcCtD
Icatibant—Body temperature increased—Phenobarbital—epilepsy syndrome	0.000682	0.00725	CcSEcCtD
Icatibant—Nausea—Primidone—epilepsy syndrome	0.000658	0.00699	CcSEcCtD
Icatibant—Anaphylactic shock—Propofol—epilepsy syndrome	0.000639	0.00679	CcSEcCtD
Icatibant—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000636	0.00676	CcSEcCtD
Icatibant—Body temperature increased—Lacosamide—epilepsy syndrome	0.000629	0.00668	CcSEcCtD
Icatibant—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000625	0.00665	CcSEcCtD
Icatibant—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000624	0.00663	CcSEcCtD
Icatibant—Rash—Trimethadione—epilepsy syndrome	0.000614	0.00653	CcSEcCtD
Icatibant—Dermatitis—Trimethadione—epilepsy syndrome	0.000614	0.00653	CcSEcCtD
Icatibant—Nervous system disorder—Midazolam—epilepsy syndrome	0.000613	0.00652	CcSEcCtD
Icatibant—Headache—Trimethadione—epilepsy syndrome	0.00061	0.00649	CcSEcCtD
Icatibant—Body temperature increased—Clobazam—epilepsy syndrome	0.00061	0.00649	CcSEcCtD
Icatibant—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000606	0.00644	CcSEcCtD
Icatibant—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000596	0.00633	CcSEcCtD
Icatibant—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000586	0.00623	CcSEcCtD
Icatibant—Nausea—Trimethadione—epilepsy syndrome	0.000579	0.00615	CcSEcCtD
Icatibant—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000572	0.00608	CcSEcCtD
Icatibant—Dizziness—Phenobarbital—epilepsy syndrome	0.000571	0.00607	CcSEcCtD
Icatibant—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.00057	0.00606	CcSEcCtD
Icatibant—Nervous system disorder—Diazepam—epilepsy syndrome	0.000561	0.00596	CcSEcCtD
Icatibant—Dizziness—Rufinamide—epilepsy syndrome	0.00056	0.00595	CcSEcCtD
Icatibant—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000553	0.00588	CcSEcCtD
Icatibant—Rash—Phenobarbital—epilepsy syndrome	0.000544	0.00578	CcSEcCtD
Icatibant—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000544	0.00578	CcSEcCtD
Icatibant—Dermatitis—Phenobarbital—epilepsy syndrome	0.000544	0.00578	CcSEcCtD
Icatibant—Headache—Phenobarbital—epilepsy syndrome	0.000541	0.00575	CcSEcCtD
Icatibant—Rash—Rufinamide—epilepsy syndrome	0.000534	0.00568	CcSEcCtD
Icatibant—Dermatitis—Rufinamide—epilepsy syndrome	0.000534	0.00567	CcSEcCtD
Icatibant—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000531	0.00565	CcSEcCtD
Icatibant—Headache—Rufinamide—epilepsy syndrome	0.000531	0.00564	CcSEcCtD
Icatibant—Dizziness—Lacosamide—epilepsy syndrome	0.000526	0.00559	CcSEcCtD
Icatibant—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000522	0.00555	CcSEcCtD
Icatibant—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000519	0.00551	CcSEcCtD
Icatibant—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000516	0.00548	CcSEcCtD
Icatibant—Nausea—Phenobarbital—epilepsy syndrome	0.000513	0.00545	CcSEcCtD
Icatibant—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000512	0.00544	CcSEcCtD
Icatibant—Dizziness—Clobazam—epilepsy syndrome	0.00051	0.00543	CcSEcCtD
Icatibant—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000509	0.00541	CcSEcCtD
Icatibant—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000506	0.00538	CcSEcCtD
Icatibant—Body temperature increased—Propofol—epilepsy syndrome	0.000505	0.00537	CcSEcCtD
Icatibant—Nausea—Rufinamide—epilepsy syndrome	0.000503	0.00535	CcSEcCtD
Icatibant—Rash—Lacosamide—epilepsy syndrome	0.000502	0.00533	CcSEcCtD
Icatibant—Dermatitis—Lacosamide—epilepsy syndrome	0.000501	0.00533	CcSEcCtD
Icatibant—Headache—Lacosamide—epilepsy syndrome	0.000498	0.0053	CcSEcCtD
Icatibant—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000495	0.00526	CcSEcCtD
Icatibant—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000488	0.00519	CcSEcCtD
Icatibant—Rash—Clobazam—epilepsy syndrome	0.000487	0.00517	CcSEcCtD
Icatibant—Dermatitis—Clobazam—epilepsy syndrome	0.000486	0.00517	CcSEcCtD
Icatibant—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000486	0.00516	CcSEcCtD
Icatibant—Headache—Clobazam—epilepsy syndrome	0.000484	0.00514	CcSEcCtD
Icatibant—Nausea—Lacosamide—epilepsy syndrome	0.000472	0.00502	CcSEcCtD
Icatibant—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000471	0.00501	CcSEcCtD
Icatibant—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000469	0.00499	CcSEcCtD
Icatibant—Hypersensitivity—Midazolam—epilepsy syndrome	0.000461	0.0049	CcSEcCtD
Icatibant—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000459	0.00488	CcSEcCtD
Icatibant—Nausea—Clobazam—epilepsy syndrome	0.000459	0.00487	CcSEcCtD
Icatibant—Dizziness—Acetazolamide—epilepsy syndrome	0.000455	0.00484	CcSEcCtD
Icatibant—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000455	0.00484	CcSEcCtD
Icatibant—Body temperature increased—Felbamate—epilepsy syndrome	0.000438	0.00465	CcSEcCtD
Icatibant—Headache—Acetazolamide—epilepsy syndrome	0.000431	0.00458	CcSEcCtD
Icatibant—Body temperature increased—Zonisamide—epilepsy syndrome	0.000428	0.00455	CcSEcCtD
Icatibant—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000428	0.00455	CcSEcCtD
Icatibant—Dizziness—Propofol—epilepsy syndrome	0.000423	0.00449	CcSEcCtD
Icatibant—Hypersensitivity—Diazepam—epilepsy syndrome	0.000421	0.00448	CcSEcCtD
Icatibant—Dizziness—Midazolam—epilepsy syndrome	0.000413	0.0044	CcSEcCtD
Icatibant—Body temperature increased—Clonazepam—epilepsy syndrome	0.000413	0.00439	CcSEcCtD
Icatibant—Body temperature increased—Phenytoin—epilepsy syndrome	0.00041	0.00436	CcSEcCtD
Icatibant—Nausea—Acetazolamide—epilepsy syndrome	0.000409	0.00434	CcSEcCtD
Icatibant—Dizziness—Levetiracetam—epilepsy syndrome	0.000408	0.00434	CcSEcCtD
Icatibant—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000408	0.00434	CcSEcCtD
Icatibant—Rash—Propofol—epilepsy syndrome	0.000403	0.00428	CcSEcCtD
Icatibant—Dermatitis—Propofol—epilepsy syndrome	0.000403	0.00428	CcSEcCtD
Icatibant—Headache—Propofol—epilepsy syndrome	0.0004	0.00426	CcSEcCtD
Icatibant—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000399	0.00424	CcSEcCtD
Icatibant—Rash—Midazolam—epilepsy syndrome	0.000394	0.00419	CcSEcCtD
Icatibant—Dizziness—Fosphenytoin—epilepsy syndrome	0.000394	0.00419	CcSEcCtD
Icatibant—Dermatitis—Midazolam—epilepsy syndrome	0.000394	0.00419	CcSEcCtD
Icatibant—Headache—Midazolam—epilepsy syndrome	0.000392	0.00416	CcSEcCtD
Icatibant—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000391	0.00416	CcSEcCtD
Icatibant—Rash—Levetiracetam—epilepsy syndrome	0.000389	0.00414	CcSEcCtD
Icatibant—Dermatitis—Levetiracetam—epilepsy syndrome	0.000389	0.00413	CcSEcCtD
Icatibant—Headache—Levetiracetam—epilepsy syndrome	0.000387	0.00411	CcSEcCtD
Icatibant—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000385	0.00409	CcSEcCtD
Icatibant—Dizziness—Vigabatrin—epilepsy syndrome	0.000384	0.00408	CcSEcCtD
Icatibant—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000382	0.00406	CcSEcCtD
Icatibant—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00038	0.00404	CcSEcCtD
Icatibant—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00038	0.00404	CcSEcCtD
Icatibant—Nausea—Propofol—epilepsy syndrome	0.00038	0.00404	CcSEcCtD
Icatibant—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000378	0.00402	CcSEcCtD
Icatibant—Dizziness—Diazepam—epilepsy syndrome	0.000378	0.00402	CcSEcCtD
Icatibant—Rash—Fosphenytoin—epilepsy syndrome	0.000376	0.00399	CcSEcCtD
Icatibant—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000375	0.00399	CcSEcCtD
Icatibant—Headache—Fosphenytoin—epilepsy syndrome	0.000373	0.00397	CcSEcCtD
Icatibant—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000373	0.00396	CcSEcCtD
Icatibant—Nausea—Midazolam—epilepsy syndrome	0.000371	0.00395	CcSEcCtD
Icatibant—Nausea—Levetiracetam—epilepsy syndrome	0.000367	0.0039	CcSEcCtD
Icatibant—Rash—Vigabatrin—epilepsy syndrome	0.000366	0.00389	CcSEcCtD
Icatibant—Dizziness—Felbamate—epilepsy syndrome	0.000366	0.00389	CcSEcCtD
Icatibant—Dermatitis—Vigabatrin—epilepsy syndrome	0.000366	0.00389	CcSEcCtD
Icatibant—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000365	0.00388	CcSEcCtD
Icatibant—Headache—Vigabatrin—epilepsy syndrome	0.000364	0.00387	CcSEcCtD
Icatibant—Rash—Diazepam—epilepsy syndrome	0.000361	0.00383	CcSEcCtD
Icatibant—Dermatitis—Diazepam—epilepsy syndrome	0.00036	0.00383	CcSEcCtD
Icatibant—Dizziness—Zonisamide—epilepsy syndrome	0.000358	0.00381	CcSEcCtD
Icatibant—Headache—Diazepam—epilepsy syndrome	0.000358	0.00381	CcSEcCtD
Icatibant—Nausea—Fosphenytoin—epilepsy syndrome	0.000354	0.00376	CcSEcCtD
Icatibant—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000353	0.00375	CcSEcCtD
Icatibant—Rash—Felbamate—epilepsy syndrome	0.000349	0.00371	CcSEcCtD
Icatibant—Dermatitis—Felbamate—epilepsy syndrome	0.000349	0.00371	CcSEcCtD
Icatibant—Headache—Felbamate—epilepsy syndrome	0.000347	0.00369	CcSEcCtD
Icatibant—Dizziness—Clonazepam—epilepsy syndrome	0.000345	0.00367	CcSEcCtD
Icatibant—Nausea—Vigabatrin—epilepsy syndrome	0.000345	0.00367	CcSEcCtD
Icatibant—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000344	0.00365	CcSEcCtD
Icatibant—Dizziness—Phenytoin—epilepsy syndrome	0.000343	0.00365	CcSEcCtD
Icatibant—Rash—Zonisamide—epilepsy syndrome	0.000342	0.00363	CcSEcCtD
Icatibant—Dermatitis—Zonisamide—epilepsy syndrome	0.000341	0.00363	CcSEcCtD
Icatibant—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000341	0.00363	CcSEcCtD
Icatibant—Nausea—Diazepam—epilepsy syndrome	0.00034	0.00361	CcSEcCtD
Icatibant—Headache—Zonisamide—epilepsy syndrome	0.000339	0.00361	CcSEcCtD
Icatibant—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000337	0.00358	CcSEcCtD
Icatibant—Rash—Clonazepam—epilepsy syndrome	0.000329	0.0035	CcSEcCtD
Icatibant—Dermatitis—Clonazepam—epilepsy syndrome	0.000329	0.0035	CcSEcCtD
Icatibant—Nausea—Felbamate—epilepsy syndrome	0.000329	0.00349	CcSEcCtD
Icatibant—Dizziness—Carbamazepine—epilepsy syndrome	0.000327	0.00348	CcSEcCtD
Icatibant—Headache—Clonazepam—epilepsy syndrome	0.000327	0.00348	CcSEcCtD
Icatibant—Rash—Phenytoin—epilepsy syndrome	0.000327	0.00348	CcSEcCtD
Icatibant—Dermatitis—Phenytoin—epilepsy syndrome	0.000327	0.00347	CcSEcCtD
Icatibant—Rash—Oxcarbazepine—epilepsy syndrome	0.000325	0.00346	CcSEcCtD
Icatibant—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000325	0.00345	CcSEcCtD
Icatibant—Headache—Phenytoin—epilepsy syndrome	0.000325	0.00345	CcSEcCtD
Icatibant—Headache—Oxcarbazepine—epilepsy syndrome	0.000323	0.00344	CcSEcCtD
Icatibant—Nausea—Zonisamide—epilepsy syndrome	0.000322	0.00342	CcSEcCtD
Icatibant—Dizziness—Lamotrigine—epilepsy syndrome	0.000316	0.00336	CcSEcCtD
Icatibant—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000315	0.00335	CcSEcCtD
Icatibant—Rash—Carbamazepine—epilepsy syndrome	0.000312	0.00332	CcSEcCtD
Icatibant—Dermatitis—Carbamazepine—epilepsy syndrome	0.000312	0.00332	CcSEcCtD
Icatibant—Nausea—Clonazepam—epilepsy syndrome	0.00031	0.0033	CcSEcCtD
Icatibant—Headache—Carbamazepine—epilepsy syndrome	0.00031	0.0033	CcSEcCtD
Icatibant—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000309	0.00329	CcSEcCtD
Icatibant—Nausea—Phenytoin—epilepsy syndrome	0.000308	0.00327	CcSEcCtD
Icatibant—Nausea—Oxcarbazepine—epilepsy syndrome	0.000306	0.00326	CcSEcCtD
Icatibant—Rash—Lamotrigine—epilepsy syndrome	0.000302	0.00321	CcSEcCtD
Icatibant—Dermatitis—Lamotrigine—epilepsy syndrome	0.000301	0.0032	CcSEcCtD
Icatibant—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000301	0.00319	CcSEcCtD
Icatibant—Headache—Lamotrigine—epilepsy syndrome	0.0003	0.00319	CcSEcCtD
Icatibant—Nausea—Carbamazepine—epilepsy syndrome	0.000294	0.00313	CcSEcCtD
Icatibant—Nausea—Lamotrigine—epilepsy syndrome	0.000284	0.00302	CcSEcCtD
Icatibant—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00028	0.00298	CcSEcCtD
Icatibant—Body temperature increased—Pregabalin—epilepsy syndrome	0.000272	0.00289	CcSEcCtD
Icatibant—Nervous system disorder—Topiramate—epilepsy syndrome	0.00026	0.00276	CcSEcCtD
Icatibant—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000253	0.00269	CcSEcCtD
Icatibant—Dizziness—Valproic Acid—epilepsy syndrome	0.000251	0.00267	CcSEcCtD
Icatibant—Body temperature increased—Gabapentin—epilepsy syndrome	0.000249	0.00265	CcSEcCtD
Icatibant—Rash—Valproic Acid—epilepsy syndrome	0.00024	0.00255	CcSEcCtD
Icatibant—Dermatitis—Valproic Acid—epilepsy syndrome	0.00024	0.00255	CcSEcCtD
Icatibant—Headache—Valproic Acid—epilepsy syndrome	0.000238	0.00253	CcSEcCtD
Icatibant—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000232	0.00247	CcSEcCtD
Icatibant—Dizziness—Pregabalin—epilepsy syndrome	0.000227	0.00242	CcSEcCtD
Icatibant—Nausea—Valproic Acid—epilepsy syndrome	0.000226	0.0024	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000224	0.00156	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—GABBR1—epilepsy syndrome	0.00022	0.00153	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.000219	0.00152	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.000219	0.00152	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000218	0.00151	CbGpPWpGaD
Icatibant—Rash—Pregabalin—epilepsy syndrome	0.000217	0.0023	CcSEcCtD
Icatibant—Dermatitis—Pregabalin—epilepsy syndrome	0.000217	0.0023	CcSEcCtD
Icatibant—Headache—Pregabalin—epilepsy syndrome	0.000215	0.00229	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000215	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000215	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000214	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HRH3—epilepsy syndrome	0.000211	0.00146	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—epilepsy syndrome	0.000211	0.00146	CbGpPWpGaD
Icatibant—Body temperature increased—Topiramate—epilepsy syndrome	0.00021	0.00223	CcSEcCtD
Icatibant—BDKRB2—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000209	0.00145	CbGpPWpGaD
Icatibant—Dizziness—Gabapentin—epilepsy syndrome	0.000208	0.00222	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000208	0.00144	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR10—epilepsy syndrome	0.000206	0.00143	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000206	0.00143	CbGpPWpGaD
Icatibant—Nausea—Pregabalin—epilepsy syndrome	0.000204	0.00217	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000202	0.0014	CbGpPWpGaD
Icatibant—Rash—Gabapentin—epilepsy syndrome	0.000199	0.00211	CcSEcCtD
Icatibant—Dermatitis—Gabapentin—epilepsy syndrome	0.000199	0.00211	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000199	0.00138	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000198	0.00137	CbGpPWpGaD
Icatibant—Headache—Gabapentin—epilepsy syndrome	0.000197	0.0021	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000197	0.00137	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR3—epilepsy syndrome	0.000196	0.00136	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—AGT—epilepsy syndrome	0.000196	0.00136	CbGpPWpGaD
Icatibant—Hypersensitivity—Topiramate—epilepsy syndrome	0.000195	0.00208	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—NPY—epilepsy syndrome	0.000191	0.00133	CbGpPWpGaD
Icatibant—Nausea—Gabapentin—epilepsy syndrome	0.000187	0.00199	CcSEcCtD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000187	0.0013	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL3—epilepsy syndrome	0.000185	0.00128	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CRH—epilepsy syndrome	0.000185	0.00128	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—OXT—epilepsy syndrome	0.000185	0.00128	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000185	0.00128	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM2—epilepsy syndrome	0.00018	0.00125	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.00018	0.00125	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—epilepsy syndrome	0.000178	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000177	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—FGF2—epilepsy syndrome	0.000177	0.00123	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—BCL2—epilepsy syndrome	0.000176	0.00122	CbGpPWpGaD
Icatibant—Dizziness—Topiramate—epilepsy syndrome	0.000175	0.00186	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000172	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000169	0.00117	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000169	0.00117	CbGpPWpGaD
Icatibant—Rash—Topiramate—epilepsy syndrome	0.000167	0.00178	CcSEcCtD
Icatibant—Dermatitis—Topiramate—epilepsy syndrome	0.000167	0.00178	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CCR2—epilepsy syndrome	0.000167	0.00116	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SST—epilepsy syndrome	0.000167	0.00116	CbGpPWpGaD
Icatibant—Headache—Topiramate—epilepsy syndrome	0.000166	0.00177	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000166	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000166	0.00115	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—AGT—epilepsy syndrome	0.000165	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000165	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—POMC—epilepsy syndrome	0.000165	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000163	0.00113	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000163	0.00113	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000163	0.00113	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000161	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	0.000161	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRDM4—epilepsy syndrome	0.000161	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000161	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM8—epilepsy syndrome	0.00016	0.00111	CbGpPWpGaD
Icatibant—Nausea—Topiramate—epilepsy syndrome	0.000158	0.00167	CcSEcCtD
Icatibant—BDKRB2—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000157	0.00109	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR8—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR9—epilepsy syndrome	0.000156	0.00108	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CNR1—epilepsy syndrome	0.000154	0.00107	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM4—epilepsy syndrome	0.000153	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM3—epilepsy syndrome	0.000153	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000153	0.00106	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—JUN—epilepsy syndrome	0.000151	0.00105	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SSTR2—epilepsy syndrome	0.00015	0.00104	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR7—epilepsy syndrome	0.00015	0.00104	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.000147	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000146	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000146	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000146	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000146	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM8—epilepsy syndrome	0.000145	0.00101	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACTB—epilepsy syndrome	0.000145	0.00101	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000141	0.00098	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ACKR4—epilepsy syndrome	0.000141	0.000975	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—POMC—epilepsy syndrome	0.000139	0.000963	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000139	0.000962	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000139	0.000962	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000138	0.000959	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GAL—epilepsy syndrome	0.000138	0.000955	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000136	0.000944	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000136	0.000944	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM1—epilepsy syndrome	0.000133	0.000922	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDYN—epilepsy syndrome	0.000133	0.000922	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR7—epilepsy syndrome	0.000133	0.000922	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000133	0.000922	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000131	0.00091	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000128	0.000888	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000128	0.000888	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR4—epilepsy syndrome	0.000127	0.000882	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR5—epilepsy syndrome	0.000127	0.000882	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AVP—epilepsy syndrome	0.000126	0.000878	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—BCHE—epilepsy syndrome	0.000125	0.000868	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GAL—epilepsy syndrome	0.000125	0.000867	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000124	0.000864	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000124	0.000857	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GRM5—epilepsy syndrome	0.000124	0.000857	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR10—epilepsy syndrome	0.000122	0.000845	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000119	0.000828	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000118	0.000822	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000117	0.000815	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000116	0.000806	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000116	0.000806	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000116	0.000806	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000113	0.000784	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000111	0.00077	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.00011	0.000766	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—PLAUR—epilepsy syndrome	0.000109	0.000755	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HRH3—epilepsy syndrome	0.000108	0.000752	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—NPY—epilepsy syndrome	0.000108	0.00075	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000108	0.000749	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—epilepsy syndrome	0.000108	0.000746	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000107	0.00074	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM2—epilepsy syndrome	0.000107	0.000739	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000105	0.00073	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000104	0.000724	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CRH—epilepsy syndrome	0.000104	0.000724	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—OXT—epilepsy syndrome	0.000104	0.000724	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR3—epilepsy syndrome	0.000101	0.000699	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—AGT—epilepsy syndrome	9.99e-05	0.000693	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—NPY—epilepsy syndrome	9.82e-05	0.000681	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR3—epilepsy syndrome	9.63e-05	0.000668	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CRH—epilepsy syndrome	9.47e-05	0.000657	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL2—epilepsy syndrome	9.47e-05	0.000657	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—OXT—epilepsy syndrome	9.47e-05	0.000657	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL3—epilepsy syndrome	9.47e-05	0.000657	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR2—epilepsy syndrome	9.43e-05	0.000654	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SST—epilepsy syndrome	9.43e-05	0.000654	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ST3GAL3—epilepsy syndrome	9.43e-05	0.000654	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR9—epilepsy syndrome	9.23e-05	0.000641	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR1—epilepsy syndrome	9.23e-05	0.000641	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPY2R—epilepsy syndrome	9.23e-05	0.000641	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ARHGEF9—epilepsy syndrome	9.23e-05	0.000641	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR8—epilepsy syndrome	9.23e-05	0.000641	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	9.23e-05	0.00064	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM3—epilepsy syndrome	9.06e-05	0.000628	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM4—epilepsy syndrome	9.06e-05	0.000628	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SSTR2—epilepsy syndrome	8.89e-05	0.000617	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DUSP4—epilepsy syndrome	8.89e-05	0.000617	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL12—epilepsy syndrome	8.87e-05	0.000615	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CNR1—epilepsy syndrome	8.7e-05	0.000604	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PLCB1—epilepsy syndrome	8.67e-05	0.000602	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM8—epilepsy syndrome	8.59e-05	0.000596	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PGF—epilepsy syndrome	8.59e-05	0.000596	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SST—epilepsy syndrome	8.57e-05	0.000594	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR2—epilepsy syndrome	8.57e-05	0.000594	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	8.49e-05	0.000589	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—POMC—epilepsy syndrome	8.41e-05	0.000583	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	8.38e-05	0.000582	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—epilepsy syndrome	8.22e-05	0.000571	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—OPRD1—epilepsy syndrome	8.19e-05	0.000568	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GNAO1—epilepsy syndrome	8.19e-05	0.000568	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	8.09e-05	0.000561	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	8.05e-05	0.000559	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CNR1—epilepsy syndrome	7.9e-05	0.000548	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	7.88e-05	0.000546	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDYN—epilepsy syndrome	7.85e-05	0.000545	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM1—epilepsy syndrome	7.85e-05	0.000545	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR7—epilepsy syndrome	7.85e-05	0.000545	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CHRM1—epilepsy syndrome	7.85e-05	0.000545	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR7—epilepsy syndrome	7.71e-05	0.000535	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—AGT—epilepsy syndrome	7.68e-05	0.000533	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	7.49e-05	0.000519	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	7.38e-05	0.000512	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GFAP—epilepsy syndrome	7.38e-05	0.000512	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GAL—epilepsy syndrome	7.38e-05	0.000512	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT3—epilepsy syndrome	7.35e-05	0.00051	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GRM5—epilepsy syndrome	7.3e-05	0.000506	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CASP2—epilepsy syndrome	7.3e-05	0.000506	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CHRM3—epilepsy syndrome	7.3e-05	0.000506	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AVP—epilepsy syndrome	7.15e-05	0.000496	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	7e-05	0.000486	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.86e-05	0.000476	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.86e-05	0.000476	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CHRM2—epilepsy syndrome	6.86e-05	0.000476	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CDC42—epilepsy syndrome	6.7e-05	0.000465	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GABBR1—epilepsy syndrome	6.68e-05	0.000463	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AVP—epilepsy syndrome	6.49e-05	0.00045	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—POMC—epilepsy syndrome	6.46e-05	0.000449	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HRH3—epilepsy syndrome	6.4e-05	0.000444	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—epilepsy syndrome	6.33e-05	0.000439	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—OPRM1—epilepsy syndrome	6.3e-05	0.000437	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	6.08e-05	0.000422	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR3—epilepsy syndrome	5.95e-05	0.000413	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.95e-05	0.000413	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NPY—epilepsy syndrome	5.8e-05	0.000402	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.8e-05	0.000402	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AGT—epilepsy syndrome	5.64e-05	0.000392	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HSPB1—epilepsy syndrome	5.59e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL2—epilepsy syndrome	5.59e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—OXT—epilepsy syndrome	5.59e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CRH—epilepsy syndrome	5.59e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL3—epilepsy syndrome	5.59e-05	0.000388	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—epilepsy syndrome	5.52e-05	0.000383	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.4e-05	0.000375	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.21e-05	0.000362	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PTK2B—epilepsy syndrome	5.2e-05	0.000361	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TSC1—epilepsy syndrome	5.2e-05	0.000361	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AGT—epilepsy syndrome	5.12e-05	0.000356	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SST—epilepsy syndrome	5.06e-05	0.000351	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NTRK2—epilepsy syndrome	5.06e-05	0.000351	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR2—epilepsy syndrome	5.06e-05	0.000351	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—DUSP6—epilepsy syndrome	5.02e-05	0.000348	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.95e-05	0.000344	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLAT—epilepsy syndrome	4.93e-05	0.000342	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL12—epilepsy syndrome	4.76e-05	0.00033	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—POMC—epilepsy syndrome	4.75e-05	0.00033	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.74e-05	0.000329	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.72e-05	0.000327	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JUNB—epilepsy syndrome	4.67e-05	0.000324	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CNR1—epilepsy syndrome	4.67e-05	0.000324	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLCB1—epilepsy syndrome	4.65e-05	0.000323	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR7—epilepsy syndrome	4.56e-05	0.000316	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HBEGF—epilepsy syndrome	4.42e-05	0.000307	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT3—epilepsy syndrome	4.34e-05	0.000301	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—POMC—epilepsy syndrome	4.31e-05	0.000299	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADAM10—epilepsy syndrome	4.24e-05	0.000294	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—epilepsy syndrome	4.22e-05	0.000293	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—S100B—epilepsy syndrome	4.01e-05	0.000278	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SOCS3—epilepsy syndrome	3.97e-05	0.000275	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CDC42—epilepsy syndrome	3.96e-05	0.000275	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AVP—epilepsy syndrome	3.83e-05	0.000266	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HES1—epilepsy syndrome	3.63e-05	0.000252	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FYN—epilepsy syndrome	3.53e-05	0.000245	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—H2AFX—epilepsy syndrome	3.51e-05	0.000244	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MEF2C—epilepsy syndrome	3.51e-05	0.000243	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.39e-05	0.000235	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NGF—epilepsy syndrome	3.35e-05	0.000233	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR5—epilepsy syndrome	3.26e-05	0.000226	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HTR2A—epilepsy syndrome	3.19e-05	0.000221	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TSC2—epilepsy syndrome	3.03e-05	0.00021	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AGT—epilepsy syndrome	3.03e-05	0.00021	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—APOE—epilepsy syndrome	2.97e-05	0.000206	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—KDR—epilepsy syndrome	2.91e-05	0.000202	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRKCB—epilepsy syndrome	2.8e-05	0.000194	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6ST—epilepsy syndrome	2.79e-05	0.000193	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—POMC—epilepsy syndrome	2.55e-05	0.000177	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-05	0.000173	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-05	0.000156	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—RELA—epilepsy syndrome	2.09e-05	0.000145	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-05	0.000142	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-05	0.000132	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-05	0.000131	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JUN—epilepsy syndrome	1.83e-05	0.000127	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-05	0.000124	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-05	0.00012	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SRC—epilepsy syndrome	1.64e-05	0.000114	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-05	0.000111	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-05	7.09e-05	CbGpPWpGaD
